WHO ICTRP trial
Evaluation of comparison between Remifentanil infusion and single dose…
IRCT2015101522173N2 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT2015101522173N2 |
|---|---|
| Public title | Evaluation of comparison between Remifentanil infusion and single dose intravenous Hydralazine + Propranolol administration to provide controlled hypotension in patients undergoing Rhino plastic surgery in khalili hospital during 2014-2015 |
| Scientific title | Evaluation of comparison between Remifentanil infusion and single dose intravenous Hydralazine + Propranolol administration to provide controlled hypotension in patients undergoing Rhino plastic surgery in khalili hospital during 2014-2015 |
| Primary sponsor | Shiraz University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 2-3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Hypertension. Hypertensive diseases;I10-I15;Hypertensive diseases |
| Interventions | Intervention 1: In group B patients are tested under Remifentanil infusion at a rate of 0.1 -0.3 mcg / kg / min . Intervention 2: Group A, besides induction of anesthesia , received 1mg Inderal and 20mg Hydralazine.;Treatment… |
| Registration date | Dec 9, 2015 |
| Target size | 80 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: